As China steps up efforts to adapt its healthcare system to support an aging population, Swiss drugmaker Roche is expanding its neuroscience footprint in the country.The company is confident that advances in diagnosis and targeted therapies can reshape treatment for neurological disorders long consi...
Liking and disliking news Highlights will help Daily News Highlights to understand visitor interests and top trends as per the user behavior hence this feature requires visitor to Sign In, if you are not registered yet, please Sing Up to personalize your reading.